BMED | XBI | BMED / XBI | |
Gain YTD | -0.480 | -5.127 | 9% |
Net Assets | 3.97M | 4.57B | 0% |
Total Expense Ratio | 0.85 | 0.35 | 243% |
Turnover | 77.00 | 90.00 | 86% |
Yield | 0.00 | 0.04 | - |
Fund Existence | 5 years | 20 years | - |
BMED | XBI | |
---|---|---|
RSI ODDS (%) | 1 day ago80% | 4 days ago90% |
Stochastic ODDS (%) | 1 day ago78% | 4 days ago90% |
Momentum ODDS (%) | 1 day ago76% | 4 days ago90% |
MACD ODDS (%) | 1 day ago77% | 4 days ago89% |
TrendWeek ODDS (%) | 1 day ago78% | 4 days ago89% |
TrendMonth ODDS (%) | 1 day ago73% | 4 days ago90% |
Advances ODDS (%) | 4 days ago82% | 20 days ago90% |
Declines ODDS (%) | 12 days ago78% | 5 days ago90% |
BollingerBands ODDS (%) | 1 day ago86% | 4 days ago90% |
Aroon ODDS (%) | 1 day ago73% | 4 days ago87% |
A.I.dvisor indicates that over the last year, BMED has been loosely correlated with A. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if BMED jumps, then A could also see price increases.
Ticker / NAME | Correlation To BMED | 1D Price Change % | ||
---|---|---|---|---|
BMED | 100% | -0.14% | ||
A - BMED | 64% Loosely correlated | -0.43% | ||
TMO - BMED | 61% Loosely correlated | +0.36% | ||
IRON - BMED | 53% Loosely correlated | +0.97% | ||
PFE - BMED | 52% Loosely correlated | N/A | ||
SYRE - BMED | 49% Loosely correlated | +0.07% | ||
More |
A.I.dvisor indicates that over the last year, XBI has been closely correlated with IDYA. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if XBI jumps, then IDYA could also see price increases.
Ticker / NAME | Correlation To XBI | 1D Price Change % | ||
---|---|---|---|---|
XBI | 100% | N/A | ||
IDYA - XBI | 74% Closely correlated | -1.13% | ||
SYRE - XBI | 72% Closely correlated | +0.07% | ||
BEAM - XBI | 72% Closely correlated | -2.58% | ||
CRNX - XBI | 71% Closely correlated | +1.97% | ||
ROIV - XBI | 70% Closely correlated | -2.79% | ||
More |